Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-22-022532
Filing Date
2022-09-15
Accepted
2022-09-15 16:16:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 nby20220914_424b3.htm 424B3 10675
2 logo03.jpg GRAPHIC 19144
  Complete submission text file 0001437749-22-022532.txt   38130
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-248238 | Film No.: 221245954
SIC: 2834 Pharmaceutical Preparations